BiOasis: Fiscal 4Q Earnings Snapshot
Posted Jun 29, 2020 4:14 pm.
Last Updated Jun 29, 2020 4:30 pm.
This article is more than 5 years old.
GUILFORD, Conn. (AP) _ Bioasis Technologies Inc. (BIOAF) on Monday reported a loss of $757,000 in its fiscal fourth quarter.
The Guilford, Connecticut-based company said it had a loss of 2 cents per share.
The biotech drug developer posted revenue of $26,100 in the period. Its adjusted revenue was $26,000.
For the year, the company reported that its loss widened to $3.1 million, or 5 cents per share. Revenue was reported as $460,000.
In the final minutes of trading on Monday, the company’s shares hit 19 cents. A year ago, they were trading at 20 cents.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BIOAF at https://www.zacks.com/ap/BIOAF
The Associated Press
